Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Ltd. has announced that its Retail Entitlement Offer is now fully underwritten by Bell Potter Securities Limited and Taylor Collison Limited. This move could enhance investor confidence and potentially stabilize the company’s stock price amid the accelerated non-renounceable entitlement offer.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
